Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Friday, November 13, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
World News
Page 190
World News
World News
ΕΠΙΣΤΗΜΟΝΙΚΑ ΝΕΑ
ΖΩΝΤΑΣ ΜΕ ΚΑΡΚΙΝΟ
ΚΑΡΚΙΝΟΣ
ΚΕΝΤΡΑ ΚΑΡΚΙΝΟΥ – ΟΓΚΟΛΟΓΟΙ
Myths and Facts
ΝΕΑ - ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
ΤΥΠΟΙ ΚΑΡΚΙΝΟΥ
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
FDA Proposes Rule Prohibiting Menthol Cigarettes
Ogkologos
-
June 27, 2022
0
Age and Frailty Should Be Considered Independently When Evaluating Potential Risk...
Ogkologos
-
June 27, 2022
0
FDA Approves Tisagenlecleucel for Relapsed or Refractory Follicular Lymphoma
Ogkologos
-
June 24, 2022
0
Health inequalities: Why is it harder for some people to eat...
Ogkologos
-
June 24, 2022
0
EMA Issues Direct Healthcare Professional Communications for Crizotinib-Related Vision Disorders in...
Ogkologos
-
June 24, 2022
0
¿Puede el uso de aceites esenciales ayudar a tratar el cáncer...
Ogkologos
-
June 23, 2022
0
Active Surveillance for Low-Risk Prostate Cancer Continues to Rise
Ogkologos
-
June 23, 2022
0
‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges...
Ogkologos
-
June 23, 2022
0
An Updated Overview of Estimates for Cancer Incidence and Mortality in...
Ogkologos
-
June 23, 2022
0
Risk of Anal Cancer Significantly Lower with Treatment for Anal High-Grade...
Ogkologos
-
June 22, 2022
0
1
...
189
190
191
...
432
Page 190 of 432
MOST POPULAR
Women in science: Cancer research pioneers – part 2
January 25, 2023
How Having a Creative Outlet Helped Me Cope During Cancer
November 8, 2022
Quizartinib Approval Adds New Treatment Option for AML, Including in Older...
August 15, 2023
Couple Married For 48 Years Shared A Touching Moment As They...
August 22, 2019
Load more
HOT NEWS
Disease in a dish: Mini-gut organoids and the challenges of bowel...
Promising Activity of Patritumab Deruxtecan in Patients with HR-positive, HER2-negative MBC...
Neoadjuvant Pembrolizumab Associated with Limited Side Effects and High Clinical Activity...
FDA Granted Accelerated Approval to Belantamab Mafodotin-blmf for Multiple Myeloma
Ελληνικά
English (UK)